Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome

Elisabeth E. Mlynarski, Molly B. Sheridan, Michael Xie, Tingwei Guo, Silvia Racedo, Donna M. McDonald-Mcginn, Xiaowu Gai, Eva W C Chow, Jacob Vorstman, Ann Swillen, Koen Devriendt, Jeroen Breckpot, Maria Cristina Digilio, Bruno Marino, Bruno Dallapiccola, Nicole Philip, Tony J. Simon, Amy E. Roberts, Małgorzata Piotrowicz, Carrie E. Bearden & 12 others Stephan Eliez, Doron Gothelf, Karlene Coleman, Wendy R. Kates, Marcella Devoto, Elaine Zackai, Damian Heine-Suñer, Tamim H. Shaikh, Anne S. Bassett, Elizabeth Goldmuntz, Bernice E. Morrow, Beverly S. Emanuel

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The 22q11.2 deletion syndrome (22q11DS; velocardiofacial/DiGeorge syndrome; VCFS/DGS) is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65% of individuals with 22q11DS have a congenital heart defect (CHD), mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants (CNVs) outside the 22q11.2 deleted region might increase the risk of being born with a CHD in this sensitized population. Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of subjects with 22q11DS separated by time of ascertainment and processing. CNV analysis was completed on a total of 949 subjects (cohort 1, n = 562; cohort 2, n = 387), 603 with CHDs (cohort 1, n = 363; cohort 2, n = 240) and 346 with normal cardiac anatomy (cohort 1, n = 199; cohort 2, n = 147). Our analysis revealed that a duplication of SLC2A3 was the most frequent CNV identified in the first cohort. It was present in 18 subjects with CHDs and 1 subject without (p = 3.12 × 10<sup>-3</sup>, two-tailed Fisher's exact test). In the second cohort, the SLC2A3 duplication was also significantly enriched in subjects with CHDs (p = 3.30 × 10<sup>-2</sup>, two-tailed Fisher's exact test). The SLC2A3 duplication was the most frequent CNV detected and the only significant finding in our combined analysis (p = 2.68 × 10<sup>-4</sup>, two-tailed Fisher's exact test), indicating that the SLC2A3 duplication might serve as a genetic modifier of CHDs and/or aortic arch anomalies in individuals with 22q11DS.

Original languageEnglish (US)
Pages (from-to)753-764
Number of pages12
JournalAmerican Journal of Human Genetics
Volume96
Issue number5
DOIs
StatePublished - May 7 2015

Fingerprint

DiGeorge Syndrome
Facilitative Glucose Transport Proteins
Congenital Heart Defects
Thoracic Aorta
Genes
Single Nucleotide Polymorphism
Anatomy
Population

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome. / Mlynarski, Elisabeth E.; Sheridan, Molly B.; Xie, Michael; Guo, Tingwei; Racedo, Silvia; McDonald-Mcginn, Donna M.; Gai, Xiaowu; Chow, Eva W C; Vorstman, Jacob; Swillen, Ann; Devriendt, Koen; Breckpot, Jeroen; Digilio, Maria Cristina; Marino, Bruno; Dallapiccola, Bruno; Philip, Nicole; Simon, Tony J.; Roberts, Amy E.; Piotrowicz, Małgorzata; Bearden, Carrie E.; Eliez, Stephan; Gothelf, Doron; Coleman, Karlene; Kates, Wendy R.; Devoto, Marcella; Zackai, Elaine; Heine-Suñer, Damian; Shaikh, Tamim H.; Bassett, Anne S.; Goldmuntz, Elizabeth; Morrow, Bernice E.; Emanuel, Beverly S.

In: American Journal of Human Genetics, Vol. 96, No. 5, 07.05.2015, p. 753-764.

Research output: Contribution to journalArticle

Mlynarski, EE, Sheridan, MB, Xie, M, Guo, T, Racedo, S, McDonald-Mcginn, DM, Gai, X, Chow, EWC, Vorstman, J, Swillen, A, Devriendt, K, Breckpot, J, Digilio, MC, Marino, B, Dallapiccola, B, Philip, N, Simon, TJ, Roberts, AE, Piotrowicz, M, Bearden, CE, Eliez, S, Gothelf, D, Coleman, K, Kates, WR, Devoto, M, Zackai, E, Heine-Suñer, D, Shaikh, TH, Bassett, AS, Goldmuntz, E, Morrow, BE & Emanuel, BS 2015, 'Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome', American Journal of Human Genetics, vol. 96, no. 5, pp. 753-764. https://doi.org/10.1016/j.ajhg.2015.03.007
Mlynarski, Elisabeth E. ; Sheridan, Molly B. ; Xie, Michael ; Guo, Tingwei ; Racedo, Silvia ; McDonald-Mcginn, Donna M. ; Gai, Xiaowu ; Chow, Eva W C ; Vorstman, Jacob ; Swillen, Ann ; Devriendt, Koen ; Breckpot, Jeroen ; Digilio, Maria Cristina ; Marino, Bruno ; Dallapiccola, Bruno ; Philip, Nicole ; Simon, Tony J. ; Roberts, Amy E. ; Piotrowicz, Małgorzata ; Bearden, Carrie E. ; Eliez, Stephan ; Gothelf, Doron ; Coleman, Karlene ; Kates, Wendy R. ; Devoto, Marcella ; Zackai, Elaine ; Heine-Suñer, Damian ; Shaikh, Tamim H. ; Bassett, Anne S. ; Goldmuntz, Elizabeth ; Morrow, Bernice E. ; Emanuel, Beverly S. / Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome. In: American Journal of Human Genetics. 2015 ; Vol. 96, No. 5. pp. 753-764.
@article{61ee5d37501a4bdba052f37d993f83a8,
title = "Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome",
abstract = "The 22q11.2 deletion syndrome (22q11DS; velocardiofacial/DiGeorge syndrome; VCFS/DGS) is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65{\%} of individuals with 22q11DS have a congenital heart defect (CHD), mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants (CNVs) outside the 22q11.2 deleted region might increase the risk of being born with a CHD in this sensitized population. Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of subjects with 22q11DS separated by time of ascertainment and processing. CNV analysis was completed on a total of 949 subjects (cohort 1, n = 562; cohort 2, n = 387), 603 with CHDs (cohort 1, n = 363; cohort 2, n = 240) and 346 with normal cardiac anatomy (cohort 1, n = 199; cohort 2, n = 147). Our analysis revealed that a duplication of SLC2A3 was the most frequent CNV identified in the first cohort. It was present in 18 subjects with CHDs and 1 subject without (p = 3.12 × 10-3, two-tailed Fisher's exact test). In the second cohort, the SLC2A3 duplication was also significantly enriched in subjects with CHDs (p = 3.30 × 10-2, two-tailed Fisher's exact test). The SLC2A3 duplication was the most frequent CNV detected and the only significant finding in our combined analysis (p = 2.68 × 10-4, two-tailed Fisher's exact test), indicating that the SLC2A3 duplication might serve as a genetic modifier of CHDs and/or aortic arch anomalies in individuals with 22q11DS.",
author = "Mlynarski, {Elisabeth E.} and Sheridan, {Molly B.} and Michael Xie and Tingwei Guo and Silvia Racedo and McDonald-Mcginn, {Donna M.} and Xiaowu Gai and Chow, {Eva W C} and Jacob Vorstman and Ann Swillen and Koen Devriendt and Jeroen Breckpot and Digilio, {Maria Cristina} and Bruno Marino and Bruno Dallapiccola and Nicole Philip and Simon, {Tony J.} and Roberts, {Amy E.} and Małgorzata Piotrowicz and Bearden, {Carrie E.} and Stephan Eliez and Doron Gothelf and Karlene Coleman and Kates, {Wendy R.} and Marcella Devoto and Elaine Zackai and Damian Heine-Su{\~n}er and Shaikh, {Tamim H.} and Bassett, {Anne S.} and Elizabeth Goldmuntz and Morrow, {Bernice E.} and Emanuel, {Beverly S.}",
year = "2015",
month = "5",
day = "7",
doi = "10.1016/j.ajhg.2015.03.007",
language = "English (US)",
volume = "96",
pages = "753--764",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Copy-number variation of the glucose transporter gene SLC2A3 and congenital heart defects in the 22q11.2 deletion syndrome

AU - Mlynarski, Elisabeth E.

AU - Sheridan, Molly B.

AU - Xie, Michael

AU - Guo, Tingwei

AU - Racedo, Silvia

AU - McDonald-Mcginn, Donna M.

AU - Gai, Xiaowu

AU - Chow, Eva W C

AU - Vorstman, Jacob

AU - Swillen, Ann

AU - Devriendt, Koen

AU - Breckpot, Jeroen

AU - Digilio, Maria Cristina

AU - Marino, Bruno

AU - Dallapiccola, Bruno

AU - Philip, Nicole

AU - Simon, Tony J.

AU - Roberts, Amy E.

AU - Piotrowicz, Małgorzata

AU - Bearden, Carrie E.

AU - Eliez, Stephan

AU - Gothelf, Doron

AU - Coleman, Karlene

AU - Kates, Wendy R.

AU - Devoto, Marcella

AU - Zackai, Elaine

AU - Heine-Suñer, Damian

AU - Shaikh, Tamim H.

AU - Bassett, Anne S.

AU - Goldmuntz, Elizabeth

AU - Morrow, Bernice E.

AU - Emanuel, Beverly S.

PY - 2015/5/7

Y1 - 2015/5/7

N2 - The 22q11.2 deletion syndrome (22q11DS; velocardiofacial/DiGeorge syndrome; VCFS/DGS) is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65% of individuals with 22q11DS have a congenital heart defect (CHD), mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants (CNVs) outside the 22q11.2 deleted region might increase the risk of being born with a CHD in this sensitized population. Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of subjects with 22q11DS separated by time of ascertainment and processing. CNV analysis was completed on a total of 949 subjects (cohort 1, n = 562; cohort 2, n = 387), 603 with CHDs (cohort 1, n = 363; cohort 2, n = 240) and 346 with normal cardiac anatomy (cohort 1, n = 199; cohort 2, n = 147). Our analysis revealed that a duplication of SLC2A3 was the most frequent CNV identified in the first cohort. It was present in 18 subjects with CHDs and 1 subject without (p = 3.12 × 10-3, two-tailed Fisher's exact test). In the second cohort, the SLC2A3 duplication was also significantly enriched in subjects with CHDs (p = 3.30 × 10-2, two-tailed Fisher's exact test). The SLC2A3 duplication was the most frequent CNV detected and the only significant finding in our combined analysis (p = 2.68 × 10-4, two-tailed Fisher's exact test), indicating that the SLC2A3 duplication might serve as a genetic modifier of CHDs and/or aortic arch anomalies in individuals with 22q11DS.

AB - The 22q11.2 deletion syndrome (22q11DS; velocardiofacial/DiGeorge syndrome; VCFS/DGS) is the most common microdeletion syndrome and the phenotypic presentation is highly variable. Approximately 65% of individuals with 22q11DS have a congenital heart defect (CHD), mostly of the conotruncal type, and/or an aortic arch defect. The etiology of this phenotypic variability is not currently known. We hypothesized that copy-number variants (CNVs) outside the 22q11.2 deleted region might increase the risk of being born with a CHD in this sensitized population. Genotyping with Affymetrix SNP Array 6.0 was performed on two groups of subjects with 22q11DS separated by time of ascertainment and processing. CNV analysis was completed on a total of 949 subjects (cohort 1, n = 562; cohort 2, n = 387), 603 with CHDs (cohort 1, n = 363; cohort 2, n = 240) and 346 with normal cardiac anatomy (cohort 1, n = 199; cohort 2, n = 147). Our analysis revealed that a duplication of SLC2A3 was the most frequent CNV identified in the first cohort. It was present in 18 subjects with CHDs and 1 subject without (p = 3.12 × 10-3, two-tailed Fisher's exact test). In the second cohort, the SLC2A3 duplication was also significantly enriched in subjects with CHDs (p = 3.30 × 10-2, two-tailed Fisher's exact test). The SLC2A3 duplication was the most frequent CNV detected and the only significant finding in our combined analysis (p = 2.68 × 10-4, two-tailed Fisher's exact test), indicating that the SLC2A3 duplication might serve as a genetic modifier of CHDs and/or aortic arch anomalies in individuals with 22q11DS.

UR - http://www.scopus.com/inward/record.url?scp=84929282777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929282777&partnerID=8YFLogxK

U2 - 10.1016/j.ajhg.2015.03.007

DO - 10.1016/j.ajhg.2015.03.007

M3 - Article

VL - 96

SP - 753

EP - 764

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 5

ER -